This ESHG corporate satellite meeting features Element Biosciences presenting our sequencing technologies and a real-world implementation case study. CEO Molly He introduces our expanding portfolio, including the flagship AVITI
NGS platform with Avidite Base Chemistry
that delivers superior data quality and accuracy. She demonstrates the Trinity workflow, which dramatically simplifies targeted sequencing by moving hybrid capture on board the sequencer, reducing workflow time from days to hours with just a one-hour hybridization. The presentation also covers the upcoming VITARI high-throughput sequencer and AVITI24 revolutionary Direct In Sample Sequencing capabilities in cells and tissues, without library preparation.
NGS platform with Avidite Base Chemistry that delivers superior data quality and accuracy. She demonstrates the Trinity workflow, which dramatically simplifies targeted sequencing by moving hybrid capture on board the sequencer, reducing workflow time from days to hours with just a one-hour hybridization. The presentation also covers the upcoming VITARI high-throughput sequencer and AVITI24 revolutionary Direct In Sample Sequencing capabilities in cells and tissues, without library preparation.Moa Hägglund from Clinical Genomics Stockholm then shares their evaluation results of Trinity workflow implementation, showing promising outcomes including reduced turnaround times by 1-2 days, lower off-target rates requiring less sequencing data for equivalent coverage, and successful detection of known somatic mutations in myeloid malignancy gene panels. The session concludes with Q&A covering practical implementation aspects like multiplexing different gene panels and working with lower quality samples.